Meanwhile, during the WSJ event in Davos this week, Pfizer’s Bourla also took aim at the Trump administration’s moves to cut ...

During an appearance on CBS News Sunday, Pfizer CEO Albert Bourla said that Americans would need a fourth dose of a COVID-19 vaccine to fend off future variants of the virus. Speaking with anchor ...

Pfizer (PFE) CEO and chairman Albert Bourla told Yahoo Finance Executive Editor Brian Sozzi during Yahoo Finance's annual Investconference that the $10 billion acquisition of GLP-1 maker Metsera (MTSR ...

Pfizer's CEO thinks his company will make big waves in the weight loss market. Eli Lilly does have a strong hold on the industry and won't let go anytime soon. Even so, Lilly could carve out a niche ...

On Tuesday, President Donald Trump, health leaders and the CEO of Pfizer announced a new drug pricing deal. The announcement, which Trump made with Pfizer CEO Albert Bourla at the White House, came as ...

Pfizer is getting into the obesity treatment industry with a multi-billion-dollar deal for Mestera. Currently, Pfizer and Mestera don’t have an obesity drug on the market. The deal between the two ...

Pfizer’s battle with Novo Nordisk over control of obesity drug developer Metsera is getting nasty. After Pfizer apparently sealed a $4.9 billion purchase of Metsera in September, Novo Nordisk swooped ...

Pfizer signed a deal with the White House to help Americans pay lower prices for prescription drugs. This agreement removes the uncertainty hanging over Pfizer's head related to the Trump ...

President Donald Trump has announced a slew of programs aimed at saving Americans money on prescription drugs, including a new website that will allow patients to buy them directly at discounted rates ...